Chulalongkorn university
Bangkok, 10330, Thailand
Location status: Recruiting
NCT Number: NCT06034990
The objective of this study is to examine the use of different types of fluids for resuscitation in different phases of fluid management in 3 types of critically ill patients including (1) not bleeding, not septic but need volume resuscitation (representing normal condition), (2) bleeding but not septic (representing normal vascular integrity but with a loss of intravascular colloids), (3) septic (representing the condition with increase vascular permeability and endothelium damage) in the ICU within Southeast Asia.
The data are collected by a 10-min online survey administered to included physicians which will be distributed via multiple online channels through representatives of each countries.
Interested in participating?
Request Info18 year–60 year
All sexes
Observational
Bangkok, 10330, Thailand
Location status: Recruiting
The objective of this study is to examine the use of different types of fluids for resuscitation in different phases of fluid management in 3 types of critically ill patients including (1) not bleeding, not septic but need volume resuscitation (representing normal condition), (2) bleeding but not septic (representing normal vascular integrity but with a loss of intravascular colloids), (3) septic (representing the condition with increase vascular permeability and endothelium damage) in the ICU within Southeast Asia, and to determine whether co-morbidities with hypoalbuminemia, clinician specialties, hospital practice settings, geographic locations and re-imbursement limitation especially for colloids influence the practice patterns of fluid utilization in different phases in the 3 types of patients. Ultimately, the information provided by this study could also provide basic background information for the design of future clinical trials regarding fluid resuscitation strategies.
The data are collected by a 10-min online survey administered to included physicians which will be distributed via multiple online channels through representatives of each countries.
The survey will start with an inform-consent form prior to starting the survey questions which consist of 13-item questionnaire obtaining information on
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1.Physicians who worked in cardiac, neurology or pediatric ICUs
This is a cross-sectional study. The data are collected by a 10-min online survey administered to included physicians which will be distributed via online channels such as such as official website or Facebook pages of Society of intensive care or Society of nephrology of corresponding countries.
Time frame: 1/9/23-1/9/24
Preferences for fluid resuscitation in 3 types of patients (1. Septic 2. bleeding but not septic 3. not bleeding and not septic) during resuscitation and optimization phase.
Time frame: 1/9/23-1/9/24
Preferences for volume status indicators and diagnostic tools
Time frame: 1/9/23-1/9/24
Preferences for fluid resuscitation in the 3 types of patients with hypoalbuminemia including (1) cirrhosis (2) nephrotic syndrome (3) other significant hypoalbuminemia during resuscitation/optimization phase and stabilization phase
Contact information is provided by the study sponsor or research team.
Chulalongkorn University
Other
Acronym: Fluid-SEA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02398981
Bleeding, Critical Illness
Shenzhen, Guangdong, China
View Trial DetailsNCT01973829
Bleeding, Coma
Homyel, Belarus
View Trial DetailsNCT02039297
Bleeding, Coma
Scottsdale, Arizona, United States
View Trial DetailsNCT07362862
Atrophy, Critical Illness
Rochester, Minnesota, United States
View Trial Details